News
Media
Conferences
Events
Publication
CME/CE
Resources
Editorial Advisory Board
Partners
Subscribe

Opinion|Videos|February 10, 2025

Tolerability and Postcare Benefits of Laser Therapy for Patients With Pigmentary Disorders

Author(s)Corey L. Hartman, MD, FAAD

Corey Hartman, MD, FAAD, discusses how incorporating proper pre- and posttreatment protocols along with topical agents maximizes patient comfort and enhances treatment outcomes in laser therapy for pigmentary conditions.

Episodes in this series

1 KOL is featured in this series.

EP. 1 Choosing Effective Laser Devices for Improving Skin Tone and Texture

1 KOL is featured in this series.

EP. 2 Comparing Fractional and Non-Fractional Lasers for Skin Rejuvenation

1 KOL is featured in this series.

EP. 3 Deciding When to Use Combination Therapies With Lasers

1 KOL is featured in this series.

EP. 4 Advancements in Laser Safety and Precision for Diverse Skin Types

1 KOL is featured in this series.

EP. 5 Challenges of Rapid Advancements in Laser Technology

1 KOL is featured in this series.

EP. 6 Expanding Laser Benefits for Diverse Patient Populations

EP. 7 Advancing Care With Laser and Light-Based Technology in Dermatology

EP. 7 Advancing Care With Laser and Light-Based Technology in Dermatology

EP. 8 Adjusting Laser Therapy Treatment Based on Patient Access, History, and Motivation

EP. 8 Adjusting Laser Therapy Treatment Based on Patient Access, History, and Motivation

EP. 9 Benefits of a Combination Treatment Approach Using Laser Therapy

EP. 9 Benefits of a Combination Treatment Approach Using Laser Therapy

1 expert is featured in this series.

EP. 10 Using Laser Therapy for Varied Skin Types and Stages of Acne

1 expert is featured in this series.

EP. 11 Laser Therapy as an Alternative or Combination Treatment for Acne

1 expert is featured in this series.

EP. 12 Efficacy and Safety of Laser Treatment for Patients With Acne

1 expert is featured in this series.

EP. 13 Integrated Approaches to Treating Rosacea With Lasers

1 expert is featured in this series.

EP. 14 Managing Expectations and Minimizing Laser Complications

1 expert is featured in this series.

EP. 15 Melanocyte Preservation and Future Directions for Laser Technology

1 expert is featured in this series.

EP. 16 Patient Goals and Outcomes for Treating Pigmentary Issues With Laser Therapy

1 expert is featured in this series.

EP. 17 Laser Therapy Protocols in Patients With Melasma and Darker Skin Tones

1 expert is featured in this series.

EP. 18 Tolerability and Postcare Benefits of Laser Therapy for Patients With Pigmentary Disorders

EP. 19 Tailored Laser and Light-Based Therapies for Acne, Skin of Color, and Inflammatory Conditions

EP. 19 Tailored Laser and Light-Based Therapies for Acne, Skin of Color, and Inflammatory Conditions

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Related Content

Treatment Adherence in Pediatric Atopic Dermatitis

ByPeter Lio, MD,Jeff Yu, MD, MS

November 7th 2025

Roflumilast for Treatment of Pediatric Atopic Dermatitis

ByPeter Lio, MD,Jeff Yu, MD, MS

November 7th 2025

Tapinarof for Treatment of Pediatric Atopic Dermatitis

ByPeter Lio, MD,Jeff Yu, MD, MS

October 31st 2025

Ruxolitinib for Treatment of Pediatric Atopic Dermatitis

ByPeter Lio, MD,Jeff Yu, MD, MS

October 31st 2025

2 experts are featured in this series.

Long-Term Management Strategies and Key Recommendations for Clinicians in Melasma

ByNada Elbuluk, MD, MSc,Corey L. Hartman, MD, FAAD

October 28th 2025

Latest CME

‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis

‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis

Raj Chovatiya, MD, PhD, MSCI, FAAD; Michael Rubio, PA-C, MMSc

Dermalorian™ Webinar: Shedding Light on Patient-Reported Outcomes to Assess Disease Severity in Patients With Atopic Dermatitis

Dermalorian™ Webinar: Shedding Light on Patient-Reported Outcomes to Assess Disease Severity in Patients With Atopic Dermatitis

Joseph Gorelick, MSN, FNP-C

Where Do Biologics Fit Into the Management of Moderate-to-Severe Atopic Dermatitis?

Where Do Biologics Fit Into the Management of Moderate-to-Severe Atopic Dermatitis?

Brad P. Glick, DO, MPH, FAAD

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Expert Illustrations & Commentaries™: Exploring Novel Therapeutic Targets in Acne Management

Expert Illustrations & Commentaries™: Exploring Novel Therapeutic Targets in Acne Management

Hilary Baldwin; Neal Bhatia, MD

Revolutionizing Atopic Dermatitis (RAD) Conference 2026

In-Person Event

Revolutionizing Atopic Dermatitis (RAD) Conference 2026

June 17-19, 2026

Clinical Consultations™: Providing Holistic Care for Complex Cases of Psoriasis with Cardiovascular Comorbidities

Clinical Consultations™: Providing Holistic Care for Complex Cases of Psoriasis with Cardiovascular Comorbidities

Brittany Weber MD, PhD, FACC, FAHA; Lourdes M. Perez-Chada MD, MMSc

Understanding Topical Steroid Withdrawal (TSW) in Patients With Atopic Dermatitis (AD)

Understanding Topical Steroid Withdrawal (TSW) in Patients With Atopic Dermatitis (AD)

Diego Ruiz Dasilva, MD, FAAD; Brad Glick, DO, MPH. FAAD; Peter Lio, MD

Navigating Safety Data with Janus Kinase (JAK) Inhibitors in Atopic Dermatitis (AD) Management

Navigating Safety Data with Janus Kinase (JAK) Inhibitors in Atopic Dermatitis (AD) Management

Andrew Alexis, MD, MPH; Leon Kircik, MD

Assessing the Evidence for OX40-OX40L Axis Inhibition for the Treatment of Atopic Dermatitis

Assessing the Evidence for OX40-OX40L Axis Inhibition for the Treatment of Atopic Dermatitis

Johann Gudjonsson, MD, PhD; Christopher Bunick, MD, PhD

Patient, Provider, and Caregiver Connection™: Addressing Patient Challenges With Holistic Approaches to Vitiligo Management

Patient, Provider, and Caregiver Connection™: Addressing Patient Challenges With Holistic Approaches to Vitiligo Management

Andrew F. Alexis, MD, MPH; Chesahna Kindred, MD, MBA, FAAD

Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient

Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient

Douglas DiRuggiero, DMSc, MHS, PA-C; Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP

Burst CME™: Optimizing Care for Patients with Psoriasis – Incorporating a Buy-and-Bill Model for Biologic Agents into Dermatological Practice

Burst CME™: Optimizing Care for Patients with Psoriasis – Incorporating a Buy-and-Bill Model for Biologic Agents into Dermatological Practice

Jerry Bagel, MD, MS

Hidradenitis Suppurativa: Diving Deeper Into Disease Pathogenesis, Severity Assessment, and Holistic Management Approaches

Hidradenitis Suppurativa: Diving Deeper Into Disease Pathogenesis, Severity Assessment, and Holistic Management Approaches

Hadar Lev-Tov, MD; Martina Porter, MD

Trending on Dermatology Times

How AI Is Transforming Skin Cancer Diagnosis

Oral C5aR Inhibitor INF904 Shows Early Efficacy in HS and CSU Phase 2a Trials

Psoriasis Care Evolves as Oral IL-23 Blockers Show Lasting Control

Day 4 Recap: SDPA Fall 2025

Harrison Nguyen, MD, MBA, MPH’s Deep Dive into CSU, Vasculitis, and Autoimmune Blisters

© 2025 MJH Life Sciences^®

All rights reserved.